{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T18:10:01Z","timestamp":1742494201607,"version":"3.40.1"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,20]]},"DOI":"10.7759\/cureus.80894","type":"journal-article","created":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T17:34:30Z","timestamp":1742492070000},"source":"Crossref","is-referenced-by-count":0,"title":["Hypophosphatasia: Clinical Clues and Management Considerations"],"prefix":"10.7759","author":[{"given":"Jason M","family":"Corless","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan J","family":"Bartholomew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph K","family":"Kluesner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.4158\/EP-2018-0194","article-title":"Hypophosphatasia: clinical assessment and management in the adult patient-a narrative review","volume":"24","author":"Vinan-Vega MN","year":"2018","unstructured":"Vinan-Vega MN, Abate EG. Hypophosphatasia: clinical assessment and management in the adult patient-a narrative review. Endocr Pract. 2018, 24:1086-92. 10.4158\/EP-2018-0194","journal-title":"Endocr Pract"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000000286","article-title":"Adult hypophosphatasia","volume":"28","author":"Briot K","year":"2016","unstructured":"Briot K, Roux C. Adult hypophosphatasia. Curr Opin Rheumatol. 2016, 28:448-51. 10.1097\/BOR.0000000000000286","journal-title":"Curr Opin Rheumatol"},{"key":"ref3","article-title":"Clinical management of hypophosphatasia","volume":"12","author":"Bishop N","year":"2015","unstructured":"Bishop N. Clinical management of hypophosphatasia. Clin Cases Miner Bone Metab. 2015, 12:170-3.","journal-title":"Clin Cases Miner Bone Metab"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2010.12.002","article-title":"Molecular characterization of tissue-nonspecific alkaline phosphatase with an Ala to Thr substitution at position 116 associated with dominantly inherited hypophosphatasia","volume":"1812","author":"Ishida Y","year":"2011","unstructured":"Ishida Y, Komaru K, Oda K. Molecular characterization of tissue-nonspecific alkaline phosphatase with an Ala to Thr substitution at position 116 associated with dominantly inherited hypophosphatasia. Biochim Biophys Acta. 2011, 1812:326-32. 10.1016\/j.bbadis.2010.12.002","journal-title":"Biochim Biophys Acta"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.4274\/jcrpe.4549","article-title":"Clinical and genetic findings of Turkish hypophosphatasia cases","volume":"9","author":"Sa\u011flam H","year":"2017","unstructured":"Sa\u011flam H, Erd\u00f6l \u015e, Dorum S. Clinical and genetic findings of Turkish hypophosphatasia cases. J Clin Res Pediatr Endocrinol. 2017, 9:229-36. 10.4274\/jcrpe.4549","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.21037\/atm-21-2096","article-title":"Six ALPL gene variants in five children with hypophosphatasia","volume":"9","author":"Su N","year":"2021","unstructured":"Su N, Zhu M, Cheng X, Xu K, Kocijan R, Zhang H. Six ALPL gene variants in five children with hypophosphatasia. Ann Transl Med. 2021, 9:888. 10.21037\/atm-21-2096","journal-title":"Ann Transl Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-019-04921-y","article-title":"Hypophosphatasia: Canadian update on diagnosis and management","volume":"30","author":"Khan AA","year":"2019","unstructured":"Khan AA, Josse R, Kannu P, Villeneuve J, Paul T, Van Uum S, Greenberg CR. Hypophosphatasia: Canadian update on diagnosis and management. Osteoporos Int. 2019, 30:1713-22. 10.1007\/s00198-019-04921-y","journal-title":"Osteoporos Int"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22094303","article-title":"Hypophosphatasia: a unique disorder of bone mineralization","volume":"22","author":"Villa-Su\u00e1rez JM","year":"2021","unstructured":"Villa-Su\u00e1rez JM, Garc\u00eda-Fontana C, And\u00fajar-Vera F, et al.. Hypophosphatasia: a unique disorder of bone mineralization. Int J Mol Sci. 2021, 22:10.3390\/ijms22094303","journal-title":"Int J Mol Sci"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-015-3272-1","article-title":"Hypophosphatasia: an overview of the disease and its treatment","volume":"26","author":"Bianchi ML","year":"2015","unstructured":"Bianchi ML. Hypophosphatasia: an overview of the disease and its treatment. Osteoporos Int. 2015, 26:2743-57. 10.1007\/s00198-015-3272-1","journal-title":"Osteoporos Int"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2016.14","article-title":"Hypophosphatasia - aetiology, nosology, pathogenesis, diagnosis and treatment","volume":"12","author":"Whyte MP","year":"2016","unstructured":"Whyte MP. Hypophosphatasia - aetiology, nosology, pathogenesis, diagnosis and treatment. Nat Rev Endocrinol. 2016, 12:233-46. 10.1038\/nrendo.2016.14","journal-title":"Nat Rev Endocrinol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.eprac.2021.07.005","article-title":"The occurrence and burden of hypophosphatasia in an ambulatory care endocrinology practice","volume":"27","author":"Quinn HB","year":"2021","unstructured":"Quinn HB, Busch RS, Kane MP. The occurrence and burden of hypophosphatasia in an ambulatory care endocrinology practice. Endocr Pract. 2021, 27:1189-92. 10.1016\/j.eprac.2021.07.005","journal-title":"Endocr Pract"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2015-212827","article-title":"Osteomalacia with low alkaline phosphatase: a not so rare condition with important consequences","volume":"2016","author":"Belkhouribchia J","year":"2016","unstructured":"Belkhouribchia J, Bravenboer B, Meuwissen M, Velkeniers B. Osteomalacia with low alkaline phosphatase: a not so rare condition with important consequences. BMJ Case Rep. 2016, 2016:10.1136\/bcr-2015-212827","journal-title":"BMJ Case Rep"},{"key":"ref13","article-title":"Adult hypophosphatasia treated with reduced frequency of teriparatide dosing","volume":"21","author":"Polyzos SA","year":"2021","unstructured":"Polyzos SA, Tournis S, Goulas A, Kollia P, Whyte MP. Adult hypophosphatasia treated with reduced frequency of teriparatide dosing. J Musculoskelet Neuronal Interact. 2021, 21:584-9.","journal-title":"J Musculoskelet Neuronal Interact"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/311382-hypophosphatasia-clinical-clues-and-management-considerations","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T17:34:44Z","timestamp":1742492084000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/311382-hypophosphatasia-clinical-clues-and-management-considerations"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,20]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.80894","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3,20]]}}}